(Q33384098)

26 July 2017

title

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis (English)

1 reference

secondary progressive multiple sclerosis

26 July 2017

main subject

0 references

0 references

M Filippi

5

0 references

author name string

D R Altmann

1

1 reference

26 July 2017

B Jasperse

2

1 reference

26 July 2017

F Barkhof

3

1 reference

26 July 2017

K Beckmann

4

1 reference

26 July 2017

L D Kappos

6

1 reference

26 July 2017

P Molyneux

7

1 reference

26 July 2017

C H Polman

8

1 reference

26 July 2017

C Pozzilli

9

1 reference

26 July 2017

A J Thompson

10

1 reference

26 July 2017

K Wagner

11

1 reference

26 July 2017

T A Yousry

12

1 reference

26 July 2017

D H Miller

13

1 reference

26 July 2017

language of work or name

English

0 references

publication date

12 November 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

72

1 reference

26 July 2017

issue

7

1 reference

26 July 2017

page(s)

595-601

1 reference

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

The analysis of repeated 'direct' measures of change illustrated with an application in longitudinal imaging

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Axonal transection in the lesions of multiple sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Statistical methods for assessing agreement between two methods of clinical measurement

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Advances in functional and structural MR image analysis and implementation as FSL

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNbeta-1b

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Normalized accurate measurement of longitudinal brain change

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2818185

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19005170

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19005170

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19005170

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/01.WNL.0000335765.55346.FC

1 reference

26 July 2017

1 reference

26 July 2017

1 reference